RxDoctor Payments Data

Heather Shields, NP

Adult Health · Marietta, GANPI 1487079224

Payments from drug & device makers

$4,285in general payments, 2019–2025

Across 187 payments — averaging $22.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$1K
  • Viiv Healthcare Company$865
  • Merck$399
  • Insmed, Inc.$292
  • Melinta Therapeutics, LLC$261
  • La Jolla Pharmaceutical Company$230
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$4,285100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,285 in reported general payments places this provider in the 85th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Medicare billing

Part B allowed, 2024
$10,141
Medicare patients
70
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala19$79,738
GenvoyaElviteg/Cob/Emtri/Tenof Alafen16$68,274
OdefseyEmtricitab/Rilpiviri/Tenof Ala16$57,305
CabenuvaCabotegravir/Rilpivirine11$55,238
PrezcobixDarunavir/Cobicistat20$53,094
DescovyEmtricitabine/Tenofov Alafenam22$49,326
TivicayDolutegravir Sodium19$42,115
Doxycycline Hyclate23$282
Cephalexin11$99

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya, Descovy$1,015$197,33857 claims
Viiv Healthcare CompanyCabenuva, Tivicay$865$97,35230 claims
Johnson & JohnsonPrezcobix$71$53,09420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 577 adult health providers in Georgia.

Other adult health in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →